Range Financial Group purchased 38,131 shares of Hasbro worth $2.89 million, accounting for 1.04% of its U.S. equity assets under
Sify Technologies Limited will report its unaudited IFRS financial results for the second quarter on October 25, 2025, before the
The U.K.’s largest retail investment platform, Hargreaves Lansdown, warns that Bitcoin is too risky for investors due to its extreme
In September, the Federal Reserve made its first interest rate cut of the year, with more cuts expected. While investing
Validea’s guru fundamental report for NEXTERA ENERGY INC (NEE) shows that it rates highest using the Growth Investor model based
High-end collectibles are becoming popular investments, raising questions about estate planning for valuable assets. Without specialized planning, assets like art
Huobi founder, Li Lin, is collaborating with top investors to establish a $1 billion Ethereum treasury, aiming to be one
Trading in Etoiles Capital Group Co., Ltd. (Nasdaq: EFTY) has been halted by Nasdaq for additional information requested from the
Trading in Platinum Analytics Cayman Limited (Nasdaq: PLTS) has been halted by Nasdaq for additional information requested from the company.
Trading in Pitanium Limited (Nasdaq: PTNM) has been halted by the Nasdaq Stock Market® for additional information requested from the
The US FDA has approved Novo Nordisk’s Rybelsus as the only oral GLP-1 medication to reduce the risk of major
Roche’s Phase III trials of vamikibart for uveitic macular edema show promising results, with improvements in vision and reductions in
RocketFuel Payments has released an updated Crypto Invoicing Solution, allowing businesses to receive payments in stablecoin, crypto, and fiat currencies.
Macy’s new CEO, Tony Spring, is making significant changes to revamp the department store chain. With a focus on improved
Chinese electric carmaker BYD is facing regulatory uncertainty and a slowdown in economic growth in China, impacting its shares. Despite
Simon Property Group Inc. (NYSE: SPG) will report Q3 2025 earnings on Nov. 3. Analysts expect EPS of $2.20, down
Genmab A/S released updated results from its Phase 1/2 RAINFOL-01 clinical trial, showing promising efficacy of rinatabart sesutecan in patients
Updated data from the Phase 1/2 RAINFOL™-01 trial showed rinatabart sesutecan (Rina-S®) 100 mg/m2 demonstrated 50% confirmed objective response rate
Interest rates on savings accounts are falling, making it crucial to find the best rates. The national average savings account
Interest rates on money market accounts have been dropping, making it essential to compare rates to maximize earnings. The national
Kalshi’s market for the S&P 500’s year-end value has seen 12,276 in volume in the past 24 hours, with an
Nexperia, a Dutch chipmaker, has suspended salaries and work account access for employees in China, amid escalating tensions between the
The S&P 500 is a diverse index that includes technology companies and banks. The S&P 500 Growth Index focuses on
Celcuity Inc. announced clinical results from a trial combining gedatolisib with darolutamide, showing a median rPFS of 9.1 months and
Celcuity Inc. has fully enrolled the PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial, evaluating gedatolisib for advanced
